Koychev, I
Joyce, D
Barkus, E
Ettinger, U
Schmechtig, A
Dourish, C T
Dawson, G R
Craig, K J
Deakin, J F W
Article History
Received: 2 November 2015
Revised: 17 February 2016
Accepted: 19 February 2016
First Online: 17 May 2016
Competing interests
: IK has been awarded a Manchester Strategic PhD Studentship, sponsored by the University of Manchester and P1vital Ltd. The PhD project of AS was partly funded by P1vital Ltd. UE is supported by the Deutsche Forschungsgemeinschaft (Et 31/2-1). JFWD has been supported by the Manchester Biomedical Research Centre. JFWD has carried out paid consultancy work and speaking engagements for Servier, Merck Sharpe and Dohme, Astrazeneca, Janssen, and Eli Lilly. The fees are paid to the University of Manchester to reimburse them for the time taken. JFWD, GRD and CTD own shares in P1vital Ltd. EB acknowledges the support of a Young Investigator Award from NARSAD. KJC worked for P1vital Ltd at the time that this research was conducted. He is currently an employee and shareholder in Covance Inc. DJ declares no relevant conflicts of interest.